MedPath

Plasma Amino Acid Response to Whey Protein Ingestion Following 28-days of Probiotic Supplementation

Not Applicable
Completed
Conditions
Focus of Study is Amino Acid Appearace in Blood
Interventions
Dietary Supplement: Bacillus subtilis DE111
Dietary Supplement: Placebo
Registration Number
NCT04491188
Lead Sponsor
Lipscomb University
Brief Summary

Active males and females consumed a probiotic for 28-days. Before and after the intervention period, participants reported to the lab in a fasted state where they consumed 25 grams of whey protein. Following drink consumption, participants provided blood draws at 15-minute intervals. Blood samples were analyzed for amino acid concentrations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • 18-34 years old Participants must have at least 1 year of resistance training experience.
  • Free of any physical limitations, medications, and supplements that may affect performance, as determined by a health and activity questionnaire.
  • Are free of musculoskeletal injuries
  • Are not taking medications that may interfere with study measurements
Exclusion Criteria
  • Taking any other nutritional supplement or performance enhancing drug.
  • Any chronic illness that causes continuous medical care
  • Taking any other nutritional supplement or performance enhancing drug.
  • Any chronic illness that causes continuous medical care.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ProbioticBacillus subtilis DE1111 x10-9 CFU Bacillus subtilis DE111 was consumed daily for 28-days
PlaceboPlaceboMaltodextrin placebo was consumed for 28-days
Primary Outcome Measures
NameTimeMethod
Plasma Amino Acid response28-days

We measured plasma amino acid concentrations before and after the 28-day intervention

Secondary Outcome Measures
NameTimeMethod
Body Composition28-days

Body Fat Percentage (%) will be monitored before and after the intervention via Bioelectical Impedance Analysis.

Trial Locations

Locations (1)

Jeremy Townsend

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath